Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Portola's recombinant factor Xa inhibitor antidote reverses rivaroxaban effects in vivo

Sep. 14, 2011

Pfizer synthesizes novel MAP kinase-activated protein kinase 2 inhibitors

Sep. 14, 2011

Korean study identifies new risk factors for vascular dementia and Alzheimer's disease

Sep. 13, 2011

Appetite-regulating hormone gene mutation linked to panic disorder

Sep. 13, 2011

Final data disclosed from randomized menatetrenone trial in hepatocellular carcinoma

Sep. 13, 2011

Long-term phase II data presented on eliglustat in type 1 Gaucher's disease

Sep. 13, 2011

New biomarker to predict clinical outcome of sorafenib-treated hepatocellular carcinoma

Sep. 12, 2011

Long-term safety of alipogene tiparvovec evaluated in patients with lipoprotein lipase deficiency

Sep. 12, 2011

Korean University links putative oncogene to development of hepatocellular carcinoma

Sep. 12, 2011

Genentech discloses new brain-penetrant PI3K inhibitors

Sep. 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...